IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

Press releases published on July 14, 2026

Jul. 14, 2026

AlphaSense Announces Native PowerPoint and Excel AI Assistants to Automate Creation of High-Stakes Assets for Financial and Corporate Teams

Indeterminate GlobeNewswire

Jul. 14, 2026

Kaspi.kz to Announce 2nd Quarter & 1st Half 2026 Financial Results on 10th August

Indeterminate GlobeNewswire

Jul. 14, 2026

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Indeterminate GlobeNewswire

Jul. 14, 2026

ZenaTech Signs Multiple Offers to Acquire Land Surveying and Geospatial Services Companies Across the U.S., Canada and Australia, Expected to Contribute C$40 Million in Revenue During the First 12 Months Following Closing

Indeterminate GlobeNewswire

Jul. 14, 2026

ConnectOne Bank is Building the Future of Commercial Lending on nCino’s Agentic Operating System

Indeterminate GlobeNewswire

Jul. 14, 2026

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

Indeterminate GlobeNewswire

Jul. 14, 2026

Intermap Partners with NSG UP42 to Expand Access to Elevation Intelligence in Saudi Arabia

Indeterminate GlobeNewswire

Jul. 14, 2026

Xtract One Technologies Further Expands Into Pharmaceutical and Life Sciences Manufacturing With New Multi-State Deployment

Indeterminate GlobeNewswire

Jul. 14, 2026

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

Jul. 14, 2026

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

Indeterminate GlobeNewswire

Jul. 14, 2026

Pure DC Launches One of Europe’s Largest Ever AI Infrastructure Projects: Phase 1 (110MW) of an over €7.5 Billion, 550MW AI Campus in Seinäjoki, Begins Fully Leased, with Planning & Power Already Secured

Indeterminate GlobeNewswire

Jul. 14, 2026

Microchip Advances Neural Network Implementation with VectorBlox™ 3.0 Accelerator SDK

Indeterminate GlobeNewswire

Jul. 14, 2026

GoCharting Introduces GoChamp: A New Standard in Trading Competitions Using CME Group Data

Indeterminate GlobeNewswire

Jul. 14, 2026

Diana Shipping Inc. Announces the Date for the 2026 Second Quarter Financial Results, Conference Call and Webcast

Indeterminate GlobeNewswire

Jul. 14, 2026

Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

Indeterminate GlobeNewswire

Jul. 14, 2026

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Indeterminate GlobeNewswire

Jul. 14, 2026

Octave to Report Second Quarter 2026 Financial Results on August 12

Indeterminate GlobeNewswire

Jul. 14, 2026

Garrett Motion to Hold Second Quarter 2026 Financial Results Conference Call on Wednesday July 29th, 2026

Indeterminate GlobeNewswire

Jul. 14, 2026

Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company’s Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide

Indeterminate GlobeNewswire

Jul. 14, 2026

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Indeterminate GlobeNewswire